| http://purl.uniprot.org/citations/34477462 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/34477462 | http://www.w3.org/2000/01/rdf-schema#comment | "Small heat shock proteins (sHsps) protect the heart from chemotherapeutics-induced heart failure by inhibiting p53-dependent apoptosis. However, mechanism of such protection has not been elucidated yet. Here we test a hypothesis that serine phosphorylation of sHsps is essential to inhibit the doxorubicin-induced and p53-dependent apoptotic pathway. Three transgenic mice (TG) lines with cardiomyocyte-specific overexpression of human heat shock protein 27 (hHsp27), namely, wild-type [myosin heavy chain (MHC)-hHsp27], S82A single mutant [MHC-mut-hHsp27(S82A)], and trimutant [MHC-mut-hHsp27(S15A/S78A/S82A)] were generated. TG mice were treated with Dox (6 mg/kg body wt; once in a week; 4 wk) along with age-matched nontransgenic (non-TG) controls. The Dox-treated MHC-hHsp27 mice showed improved survival and cardiac function (both MRI and echocardiography) in terms of contractility [ejection fraction (%EF)] and left ventricular inner diameter (LVID) compared with the Dox-treated non-TG mice. However, both MHC-mut-hHsp27(S82A) and MHC-mut-hHsp27(S15A/S78A/S82A) mutants overexpressing TG mice did not show such a cardioprotection. Furthermore, transactivation of p53 was found to be attenuated only in Dox-treated MHC-hHsp27 mice-derived cardiomyocytes in vitro, as low p53 was detected in the nuclei, not in mutant hHsp27 overexpressing cardiomyocytes. Similarly, only in MHC-hHsp27 overexpressing cardiomyocytes, low Bax, higher mechanistic target of rapamycin (mTOR) phosphorylation, and low apoptotic poly(ADP-ribose) polymerase-1 (PARP-1) cleavage (89 kDa fragment) were detected. Pharmacological inhibition of p53 was more effective in mutant TG mice compared with MHC-hHsp27 mice. We conclude that phosphorylation of overexpressed Hsp27 at S82 and its association with p53 are essential for the cardioprotective effect of overexpressed Hsp27 against Dox-induced dilated cardiomyopathy. Only phosphorylated Hsp27 protects the heart by inhibiting p53 transactivation.NEW & NOTEWORTHY Requirement of serine phosphorylation in Hsp27 for cardioprotective effect against Dox is tested in various mutants overexpressing mice. Cardioprotective effect was found to be compromised in Hsp27 serine mutants overexpressed mice compared with wild-type overexpressing mice. These results indicate that cancer patients, who carry these mutations, may have higher risk of aggravated cardiomyopathy on treated with cardiotoxic chemotherapeutics such as doxorubicin."xsd:string |
| http://purl.uniprot.org/citations/34477462 | http://purl.org/dc/terms/identifier | "doi:10.1152/ajpheart.00027.2020"xsd:string |
| http://purl.uniprot.org/citations/34477462 | http://purl.uniprot.org/core/author | "Zweier J.L."xsd:string |
| http://purl.uniprot.org/citations/34477462 | http://purl.uniprot.org/core/author | "Kanagasabai R."xsd:string |
| http://purl.uniprot.org/citations/34477462 | http://purl.uniprot.org/core/author | "Ilangovan G."xsd:string |
| http://purl.uniprot.org/citations/34477462 | http://purl.uniprot.org/core/author | "Karthikeyan K."xsd:string |
| http://purl.uniprot.org/citations/34477462 | http://purl.uniprot.org/core/date | "2021"xsd:gYear |
| http://purl.uniprot.org/citations/34477462 | http://purl.uniprot.org/core/name | "Am J Physiol Heart Circ Physiol"xsd:string |
| http://purl.uniprot.org/citations/34477462 | http://purl.uniprot.org/core/pages | "H963-H975"xsd:string |
| http://purl.uniprot.org/citations/34477462 | http://purl.uniprot.org/core/title | "Serine mutations in overexpressed Hsp27 abrogate the protection against doxorubicin-induced p53-dependent cardiac apoptosis in mice."xsd:string |
| http://purl.uniprot.org/citations/34477462 | http://purl.uniprot.org/core/volume | "321"xsd:string |
| http://purl.uniprot.org/citations/34477462 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/34477462 |
| http://purl.uniprot.org/citations/34477462 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/34477462 |
| http://purl.uniprot.org/uniprot/#_A0A8E9ZT92-mappedCitation-34477462 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34477462 |
| http://purl.uniprot.org/uniprot/#_A0A8E9ZUD7-mappedCitation-34477462 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34477462 |
| http://purl.uniprot.org/uniprot/#_B4DL87-mappedCitation-34477462 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34477462 |
| http://purl.uniprot.org/uniprot/#_C9J3N8-mappedCitation-34477462 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34477462 |
| http://purl.uniprot.org/uniprot/#_P04792-mappedCitation-34477462 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34477462 |
| http://purl.uniprot.org/uniprot/#_V9HW43-mappedCitation-34477462 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34477462 |
| http://purl.uniprot.org/uniprot/A0A8E9ZUD7 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/34477462 |
| http://purl.uniprot.org/uniprot/C9J3N8 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/34477462 |
| http://purl.uniprot.org/uniprot/A0A8E9ZT92 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/34477462 |
| http://purl.uniprot.org/uniprot/P04792 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/34477462 |
| http://purl.uniprot.org/uniprot/V9HW43 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/34477462 |